Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2009 1
2010 2
2012 1
2013 3
2014 2
2015 6
2016 2
2018 2
2019 2
2021 3
2022 1
2023 2
2024 1
2025 3
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Eph as a target in inflammation.
Ieguchi K. Ieguchi K. Endocr Metab Immune Disord Drug Targets. 2015;15(2):119-28. doi: 10.2174/1871530315666150316121302. Endocr Metab Immune Disord Drug Targets. 2015. PMID: 25772170 Review.
Lung Tumor Cell Recruitment Assay.
Tomita T, Ieguchi K, Deguchi A, Takita M, Tsukahara F, Hiratsuka S, Maru Y. Tomita T, et al. Among authors: ieguchi k. J Vis Exp. 2019 Feb 26;(144). doi: 10.3791/53172. J Vis Exp. 2019. PMID: 30882774
Roles of EphA1/A2 and ephrin-A1 in cancer.
Ieguchi K, Maru Y. Ieguchi K, et al. Cancer Sci. 2019 Mar;110(3):841-848. doi: 10.1111/cas.13942. Epub 2019 Feb 15. Cancer Sci. 2019. PMID: 30657619 Free PMC article. Review.
Tumor Akkermansia muciniphila predicts clinical response to immune checkpoint inhibitors in non-small-cell lung cancer patients with low PD-L1 expression.
Shimizu T, Ohkuma R, Homma M, Nakayama S, Sasaki Y, Muto S, Ieguchi K, Watanabe M, Taguchi A, Takayanagi D, Wada Y, Horiike A, Kubota Y, Ariizumi H, Shimokawa M, Hirasawa Y, Ishiguro T, Suzuki R, Iriguchi N, Mura E, Yoshimura K, Tsuji M, Kiuchi Y, Suzuki H, Yamochi T. Shimizu T, et al. Among authors: ieguchi k. Front Immunol. 2025 Sep 8;16:1528594. doi: 10.3389/fimmu.2025.1528594. eCollection 2025. Front Immunol. 2025. PMID: 40990022 Free PMC article.
Elevated plasma levels of WAP four-disulfide core domain 2 as a potential prognostic biomarker for various cancers.
Watanabe M, Ieguchi K, Onishi N, Shimizu T, Ohkuma R, Suzuki R, Mura E, Iriguchi N, Ishiguro T, Hirasawa Y, Ikeda G, Shimokawa M, Ariizumi H, Horiike A, Yoshimura K, Tsunoda T, Tsuji M, Kobayashi S, Kiuchi Y, Wada S. Watanabe M, et al. Among authors: ieguchi k. Front Oncol. 2025 Jul 14;15:1614102. doi: 10.3389/fonc.2025.1614102. eCollection 2025. Front Oncol. 2025. PMID: 40727473 Free PMC article.
ADAM12-cleaved ephrin-A1 contributes to lung metastasis.
Ieguchi K, Tomita T, Omori T, Komatsu A, Deguchi A, Masuda J, Duffy SL, Coulthard MG, Boyd A, Maru Y. Ieguchi K, et al. Oncogene. 2014 Apr 24;33(17):2179-90. doi: 10.1038/onc.2013.180. Epub 2013 May 20. Oncogene. 2014. PMID: 23686306
Monocyte subsets associated with the efficacy of anti‑PD‑1 antibody monotherapy.
Ohkuma R, Fujimoto Y, Ieguchi K, Onishi N, Watanabe M, Takayanagi D, Goshima T, Horiike A, Hamada K, Ariizumi H, Hirasawa Y, Ishiguro T, Suzuki R, Iriguchi N, Tsurui T, Sasaki Y, Homma M, Yamochi T, Yoshimura K, Tsuji M, Kiuchi Y, Kobayashi S, Tsunoda T, Wada S. Ohkuma R, et al. Among authors: ieguchi k. Oncol Lett. 2023 Jul 20;26(3):381. doi: 10.3892/ol.2023.13967. eCollection 2023 Sep. Oncol Lett. 2023. PMID: 37559573 Free PMC article.
Drug Targeting Based on a New Concept-Targeting Against TLR4 as an Example.
Maru Y, Tomita T, Deguchi A, Ieguchi K, Takita M, Tsukahara F, Takemura K, Kitao A, Gusovsky F. Maru Y, et al. Among authors: ieguchi k. Endocr Metab Immune Disord Drug Targets. 2015;15(2):83-7. doi: 10.2174/187153031502150522123746. Endocr Metab Immune Disord Drug Targets. 2015. PMID: 26004773 Review.
32 results